As evidence accumulates supporting its use in neurodegenerative diseases and nerve regeneration, pharmaceutical companies are investing heavily in developing prescription-grade formulations
are living with post-bariatric hypoglycemia (PBH), which is roughly 8% of those who have undergone the two most common types of bariatric surgery, Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy, over the last decade
WAT can also be further divided into visceral adipose tissue (VAT) and subcutaneous adipose tissue [82]
That's why clinical trials showing benefit consistently use injectable formulations rather than oral equivalents
But in the short run, GI side effects like Nausea, vomiting, and diarrhea can leave you dehydrated, and dehydration can cause a temporary drop in kidney function that shows up as a rising creatinine and a falling eGFR
You could chase it with more leggings, right